Nanexa AB (publ) announced a private placement of 10,000,000 shares at a price of SEK 1.72 per share for gross proceeds of SEK 17,200,000 on December 21, 2022. The transaction included participation from existing investor Novo Nordisk A/S.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.942 SEK | -8.99% | +4.43% | -23.41% |
May. 15 | Nanexa AB Elects Hanna Tilus as Members of the Board | CI |
May. 15 | Nanexa AB Receives Approval for NEX-22 Clinical Study | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
927.3 DKK | +1.13% | -0.16% | 598B | ||
0.942 SEK | -8.99% | +4.43% | 12.13M | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.41% | 12.13M | |
+16.58% | 255M | |
-53.52% | 95.93M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa AB announced that it has received SEK 17.2 million in funding from Novo Nordisk A/S